These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19450282)

  • 41. Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana.
    Mockenhaupt FP; Bousema JT; Eggelte TA; Ehrhardt S; Otchwemah RN; Sauerwein RW; Bienzle U
    Malar J; 2005 Sep; 4():42. PubMed ID: 16164748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
    Carnevale EP; Kouri D; DaRe JT; McNamara DT; Mueller I; Zimmerman PA
    J Clin Microbiol; 2007 Mar; 45(3):752-61. PubMed ID: 17121999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: a Philippine study.
    Hatabu T; Iwagami M; Kawazu S; Taguchi N; Escueta AD; Villacorte EA; Rivera PT; Kano S
    Parasitol Int; 2009 Jun; 58(2):166-70. PubMed ID: 19567229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
    Hassen J; Alemayehu GS; Dinka H; Golassa L
    Malar J; 2022 Oct; 21(1):286. PubMed ID: 36207750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survey of Plasmodium falciparum multidrug resistance-1 and chloroquine resistance transporter alleles in Haiti.
    Elbadry MA; Existe A; Victor YS; Memnon G; Fukuda M; Dame JB; Yowell CA; Okech BA
    Malar J; 2013 Nov; 12():426. PubMed ID: 24252305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
    Ballif M; Hii J; Marfurt J; Crameri A; Fafale A; Felger I; Beck HP; Genton B
    Malar J; 2010 Oct; 9():270. PubMed ID: 20925934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
    Mbogo GW; Nankoberanyi S; Tukwasibwe S; Baliraine FN; Nsobya SL; Conrad MD; Arinaitwe E; Kamya M; Tappero J; Staedke SG; Dorsey G; Greenhouse B; Rosenthal PJ
    Am J Trop Med Hyg; 2014 Jul; 91(1):54-61. PubMed ID: 24799371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?
    Kamugisha E; Bujila I; Lahdo M; Pello-Esso S; Minde M; Kongola G; Naiwumbwe H; Kiwuwa S; Kaddumukasa M; Kironde F; Swedberg G
    Acta Trop; 2012 Feb; 121(2):148-51. PubMed ID: 22118982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
    J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in India.
    Das S; Tripathy S; Chattopadhayay S; Das B; Kar Mahapatra S; Hati AK; Roy S
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):251-261. PubMed ID: 28692943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.
    McCollum AM; Schneider KA; Griffing SM; Zhou Z; Kariuki S; Ter-Kuile F; Shi YP; Slutsker L; Lal AA; Udhayakumar V; Escalante AA
    Malar J; 2012 Mar; 11():77. PubMed ID: 22439637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China.
    Zhang GQ; Guan YY; Zheng B; Wu S; Tang LH
    Trop Med Int Health; 2009 Oct; 14(10):1266-71. PubMed ID: 19772548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.
    Gama BE; Pereira-Carvalho GA; Lutucuta Kosi FJ; Almeida de Oliveira NK; Fortes F; Rosenthal PJ; Daniel-Ribeiro CT; de Fátima Ferreira-da-Cruz M
    Malar J; 2010 Jun; 9():174. PubMed ID: 20565881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
    Ogouyèmi-Hounto A; Ndam NT; Kinde Gazard D; d'Almeida S; Koussihoude L; Ollo E; Azagnandji C; Bello M; Chippaux JP; Massougbodji A
    Malar J; 2013 May; 12():147. PubMed ID: 23634705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003.
    Mungthin M; Suwandittakul N; Chaijaroenkul W; Rungsrihirunrat K; Harnyuttanakorn P; Seugorn A; Na Bangchang K
    Parasitol Res; 2010 Aug; 107(3):539-45. PubMed ID: 20449753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests.
    Rason MA; Ariey F; Rafidimanantsoa L; Andrianantenaina BH; Sahondra Harisoa JL; Randrianarivelojosia M
    Parasite; 2002 Sep; 9(3):247-53. PubMed ID: 12375368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.
    Andriantsoanirina V; Ratsimbasoa A; Bouchier C; Tichit M; Jahevitra M; Rabearimanana S; Raherinjafy R; Mercereau-Puijalon O; Durand R; Ménard D
    PLoS One; 2010 Oct; 5(10):e13281. PubMed ID: 20967251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.